Mednow Enters Into National Distribution and Preferred Pharmacy Network (PPN) Agreement With Care Pharmacies; Announces Grant of Management Cease Trade Order
Mednow Inc. (OTCQX:MDNWF) partners with Care Pharmacies to enhance its virtual pharmacy network across Canada. This collaboration aims to improve pharmacy distribution and access through a Preferred Pharmacy Network (PPN), expanding Mednow's services to more Canadians. Mednow will charge technology fees to participating pharmacies, further boosting its revenue streams. However, the company is currently under a Management Cease Trade Order (MCTO) due to delays in filing interim financial statements, impacting its operational transparency.
- Partnership with Care Pharmacies enhances Mednow's virtual pharmacy offering.
- Expansion into new regions increases access for Canadian patients.
- Mednow will collect technology fees, improving potential revenue streams.
- Management Cease Trade Order (MCTO) issued due to missed financial filing deadlines.
- Ongoing complications in coordinating with auditors may hinder financial transparency.
-
Care Pharmacies is one of the largest consolidators of rural and remote pharmacies in
Canada , with more than 55 pharmacy locations and growing. -
Mednow utilizes its proprietary technology to offer a transformed and highly engaging virtual pharmacy experience for itsMednow for Business Client Plan members, patients and customers. -
By enhancing pharmacy distribution, regional coverage and pharmacist access via a differentiated preferred pharmacy network (“PPN”),
Mednow continues to build on itsMednow for Business offering. -
In addition to Mednow’s owned central fill pharmacies, 3rd party pharmacies that are part of Mednow’s PPN will enable
Mednow to service more Canadians with localized pharmacy fulfillment withMednow acting as the technology layer controlling their experience. -
Mednow will collect technology fees from participating pharmacies in exchange for access to members and an integrated technology solution powering 3rd party pharmacies patient engagement, communication and coordination. - This is a first step in Mednow’s strategic vision to provide Canadian patients and independent pharmacies with a consumer-driven, highly engaging front end virtual pharmacy experience and the software which can support back-end virtual pharmacy operations.
In addition to owned
“We’re thrilled to deepen our presence in
By Partnering with
Mednow Announces Grant of Management Cease
The Company applied for the MCTO in connection with missing the filing deadline of
The Company applied for the MCTO as a result of ongoing complications in coordinating with the Company’s auditors and collection of required data and documentation to complete the review of the Company and its various subsidiaries, during the period ended
The Company expects to file the Interim Filings as soon as they are available, but in any event no later than
During the MCTO, the general investing public will continue to be able to trade in the Company's Class A Common Shares listed on the
The Company is not currently subject to any insolvency proceedings. If the Company provides any information to any of its creditors during the period in which it is in default of filing the Interim Filings, the Company confirms that it will also file material change reports on SEDAR containing such information.
ON BEHALF OF THE BOARD OF DIRECTORS
Per:
Amir Ali Reyhany-Bozorg, CEO
About Care Pharmacies
Care Pharmacies is the largest Canadian group of independent pharmacies that are majority owned and controlled by Licensed Pharmacists. Care has a 15-year track record of integrity, innovation and respect for the profession of pharmacy. With over 55 locations across Canada Care Pharmacies provides key health care to traditionally underserved areas.
About
Cautionary Note Regarding Forward-Looking Statements:
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, are forward-looking statements and contain forward-looking information, including statements relating to: Mednow’s plan to expand its operations and open fulfillment centres in certain locations in 2023, Mednow’s goal of integrating the technology of its strategic business acquisitions with its core fulfillment pharmacies, the optimization of Mednow’s PillSmart TM and nutraceutical offerings, Mednow’s ability to connect with employers, specialty doctors and large pharmacies, and Mednow’s ability to acquire customers and lower costs.
Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Risk factors are set out in the Company’s final long form prospectus dated
This news release also contains future-oriented financial information and financial outlook information (collectively, “FOFI”) as defined under Canadian securities laws, prepared by Mednow’s management about Mednow’s reasonably estimated prospective results of operations, revenue, sales, and components thereof, all of which are subject to the same assumptions, risks factors, limitations and qualifications set forth in the above paragraphs. Readers are cautioned that FOFI are not guarantees of future performance, and should not be considered as such, since actual results may differ materially from those expressed in FOFI.
As a result, there can be no assurance that forward-looking information or FOFI will prove to be accurate, as actual results and future events could differ materially from those anticipated in this news release. Accordingly, readers should not place undue reliance on the forward-looking information or FOFI contained in this news release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230104005384/en/
Investor:
1-855-686-6300
ir@mednow.ca
Source:
FAQ
What is Mednow's partnership with Care Pharmacies about?
How will Mednow benefit from the Preferred Pharmacy Network?
What is the significance of the Management Cease Trade Order for Mednow?